Related Funds
Fund Name | Location |
Africa Internet Holding | Lagos, Lagos, Nigeria |
Blue Horizon Ventures | Switzerland, Zürich, Zurich |
Changying Technology | China, Guangdong Province, Maoming City |
Chisage | China, Ningbo, Zhejiang |
Concept2Company Ventures | California, Stanford, United States |
DGC | China, Guangdong, Shenzhen |
King Capital | China, Ningbo, Zhejiang |
Launch Lane | Pennsylvania, Philadelphia, United States |
Lofty Ventures | Chicago, Illinois, United States |
Mariner Wealth Advisors | Kansas, Leawood, United States |
OakStone Ventures | California, Palo Alto, United States |
Operate Studio | California, Costa Mesa, United States |
Osisko Gold Royalties Ltd | Canada, Montreal, Quebec |
Safran Corporate Ventures | France, Ile-de-France, Paris |
Specialized Types | California, San Francisco, United States |
Surveyor Capital | Chicago, Illinois, United States |
Symantec Ventures | - |
The Hive Group | Richardson, Texas, United States |
Thomson Learning | Chicago, Illinois, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Eden Farm Indonesia | $13M | 30 Jan 2023 | Jakarta, Jakarta Raya, Indonesia | ||
OmniEyes | $5M | 01 Feb 2022 | New Taipei, Taiwan | ||
Elixiron Immunotherapeutics | $27M | 23 Aug 2021 | New Taipei, Taiwan | ||
MedAware | $8M | 16 Aug 2017 | Israel, North District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Eden Farm Indonesia | $13M | 30 Jan 2023 | Jakarta, Jakarta Raya, Indonesia | ||
OmniEyes | $5M | 01 Feb 2022 | New Taipei, Taiwan | ||
Elixiron Immunotherapeutics | $27M | 23 Aug 2021 | New Taipei, Taiwan | ||
MedAware | $8M | 16 Aug 2017 | Israel, North District, Israel |